Theravance Biopharma (TBPH) Free Cash Flow (2013 - 2026)
Theravance Biopharma (TBPH) reported Free Cash Flow of $73.3 million for Q1 2026, up 70.26% year-over-year from $43.0 million in Q1 2025, and up 1306.83% on a QoQ basis from -$6.1 million in Q4 2025.
Theravance Biopharma (TBPH) has 14 years of Free Cash Flow data on file, last reported at $73.3 million in Q1 2026.
- Quarterly Free Cash Flow rose 70.26% year-over-year to $73.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $268.8 million (up 732.5% YoY) and the FY2025 annual result came in at $238.5 million, up 2109.77% from the prior year.
- Free Cash Flow rose to $73.3 million in Q1 2026 per TBPH's latest filing, from -$6.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $208.1 million in Q2 2025 and bottomed at -$124.3 million in Q4 2022.
- The 5-year median for Free Cash Flow is -$5.2 million (2024), against an average of $4.9 million.
- Peak annual rise in Free Cash Flow reached 4774.77% in 2025, while the deepest fall reached 456.04% in 2025.
- Tracing TBPH's Free Cash Flow over 5 years: stood at -$124.3 million in 2022, then surged by 98.77% to -$1.5 million in 2023, then gained by 28.67% to -$1.1 million in 2024, then slumped by 456.04% to -$6.1 million in 2025, then jumped by 1306.83% to $73.3 million in 2026.
- Per Business Quant, the three latest TBPH Free Cash Flow figures stand at $73.3 million (Q1 2026), -$6.1 million (Q4 2025), and -$6.5 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - | 73.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.28 Mn |
| Mar 31, 2026 | 73.28 Mn |
| Dec 31, 2025 | -6.07 Mn |
| Dec 31, 2025 | -6.07 Mn |
| Sep 30, 2025 | -6.51 Mn |
| Sep 30, 2025 | -6.51 Mn |
| Jun 30, 2025 | 208.07 Mn |
| Jun 30, 2025 | 208.07 Mn |
| Mar 31, 2025 | 43.04 Mn |
| Mar 31, 2025 | 43.04 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Dec 31, 2024 | -1.09 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | -4.45 Mn |
| Jun 30, 2024 | -4.45 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Mar 31, 2024 | -1.11 Mn |
| Dec 31, 2023 | -1.53 Mn |
| Dec 31, 2023 | -1.53 Mn |
| Sep 30, 2023 | -2.51 Mn |
| Sep 30, 2023 | -2.51 Mn |
| Jun 30, 2023 | -13.29 Mn |
| Jun 30, 2023 | -13.29 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Mar 31, 2023 | -12.16 Mn |
| Dec 31, 2022 | -124.32 Mn |
| Dec 31, 2022 | -124.32 Mn |
| Sep 30, 2022 | -22.47 Mn |
| Sep 30, 2022 | -22.47 Mn |
| Jun 30, 2022 | -14.45 Mn |
| Jun 30, 2022 | -14.45 Mn |
| Mar 31, 2022 | -26.32 Mn |
| Mar 31, 2022 | -26.32 Mn |
| Dec 31, 2021 | -42.88 Mn |
| Dec 31, 2021 | -42.88 Mn |
| Sep 30, 2021 | -46.49 Mn |
| Sep 30, 2021 | -46.49 Mn |
| Jun 30, 2021 | -50.27 Mn |
| Jun 30, 2021 | -50.27 Mn |
| Mar 31, 2021 | -71.63 Mn |
| Mar 31, 2021 | -71.63 Mn |
| Dec 31, 2020 | -66.17 Mn |
| Dec 31, 2020 | -66.17 Mn |
| Sep 30, 2020 | -79.08 Mn |
| Sep 30, 2020 | -79.08 Mn |
| Jun 30, 2020 | -55.71 Mn |
| Jun 30, 2020 | -55.71 Mn |
| Mar 31, 2020 | -56.06 Mn |
| Mar 31, 2020 | -56.06 Mn |
| Dec 31, 2019 | -65.66 Mn |
| Dec 31, 2019 | -65.66 Mn |
| Sep 30, 2019 | -44.70 Mn |
| Sep 30, 2019 | -44.70 Mn |
| Jun 30, 2019 | -48.61 Mn |
| Jun 30, 2019 | -48.61 Mn |
| Mar 31, 2019 | -82.41 Mn |
| Mar 31, 2019 | -82.41 Mn |
| Dec 31, 2018 | -53.68 Mn |
| Dec 31, 2018 | -53.68 Mn |
| Sep 30, 2018 | -50.85 Mn |
| Sep 30, 2018 | -50.85 Mn |
| Jun 30, 2018 | -62.63 Mn |
| Jun 30, 2018 | -62.63 Mn |
| Mar 31, 2018 | 47.05 Mn |
| Mar 31, 2018 | 47.05 Mn |
| Dec 31, 2017 | -44.46 Mn |
| Dec 31, 2017 | -44.46 Mn |
| Sep 30, 2017 | -63.13 Mn |
| Sep 30, 2017 | -63.13 Mn |
| Jun 30, 2017 | -45.26 Mn |
| Jun 30, 2017 | -45.26 Mn |
| Mar 31, 2017 | -50.61 Mn |
| Mar 31, 2017 | -50.61 Mn |
| Dec 31, 2016 | -28.51 Mn |
| Dec 31, 2016 | -28.51 Mn |
| Sep 30, 2016 | -12.85 Mn |
| Sep 30, 2016 | -12.85 Mn |
| Jun 30, 2016 | -32.77 Mn |
| Jun 30, 2016 | -32.77 Mn |
| Mar 31, 2016 | -26.99 Mn |
| Mar 31, 2016 | -26.99 Mn |
| Dec 31, 2015 | -34.35 Mn |
| Dec 31, 2015 | -34.35 Mn |
| Sep 30, 2015 | -32.66 Mn |
| Sep 30, 2015 | -32.66 Mn |
| Jun 30, 2015 | -47.32 Mn |
| Jun 30, 2015 | -47.32 Mn |
| Mar 31, 2015 | -57.17 Mn |
| Mar 31, 2015 | -57.17 Mn |
| Dec 31, 2014 | -43.30 Mn |
| Dec 31, 2014 | -43.30 Mn |
| Sep 30, 2014 | -36.84 Mn |
| Sep 30, 2014 | -36.84 Mn |
| Jun 30, 2014 | -51.70 Mn |
| Jun 30, 2014 | -51.70 Mn |
| Mar 31, 2014 | -46.42 Mn |
| Mar 31, 2014 | -46.42 Mn |
| Dec 31, 2013 | -36.25 Mn |
| Dec 31, 2013 | -36.25 Mn |
| Sep 30, 2013 | -33.17 Mn |
| Sep 30, 2013 | -33.17 Mn |
| Jun 30, 2013 | -25.04 Mn |
| Jun 30, 2013 | -25.04 Mn |
| Mar 31, 2013 | -29.23 Mn |
| Mar 31, 2013 | -29.23 Mn |